These companies offer a diverse range of diabetes treatments, such as insulin, DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors, catering to both type 1 and type 2 diabetes patients
Clinical Efficacy, Real-World Weight Loss Outcomes & Supply Constraints with Manufacturing Expansion Tirzepatide demonstrates superior weight loss compared to competitors, reinforcing its dominance in the obesity and diabetes markets
In adults with chronic constipation, 28 days of treatment with 1,500 mg magnesium oxide or 1,000 mg of senna (a stimulant laxative) per day significantly improved symptoms overall (68% and 69%, respectively) compared with placebo (almost 12%)
Rhodopsin expression has been reported in rod-shaped photoreceptor cells of the retina